{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:58:16Z","timestamp":1790193496074,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871343"],"award-info":[{"award-number":["81871343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Key"},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["BE2017699"],"award-info":[{"award-number":["BE2017699"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["BE2017698"],"award-info":[{"award-number":["BE2017698"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["BK20181226"],"award-info":[{"award-number":["BK20181226"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"Research and Development","doi-asserted-by":"publisher","award":["BE2018693"],"award-info":[{"award-number":["BE2018693"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Medical Innovation","award":["CXTDA2017010"],"award-info":[{"award-number":["CXTDA2017010"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20171311"],"award-info":[{"award-number":["BK20171311"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"six talent peaks project in Jiangsu Province","doi-asserted-by":"publisher","award":["2016-WSW-125"],"award-info":[{"award-number":["2016-WSW-125"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"name":"333 Project","award":["BRA2016141"],"award-info":[{"award-number":["BRA2016141"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jad.2019.03.008","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T12:48:34Z","timestamp":1551962914000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression"],"prefix":"10.1016","volume":"250","author":[{"given":"Yuhao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"244","key":"10.1016\/j.jad.2019.03.008_bib0001","doi-asserted-by":"crossref","first-page":"pe45","DOI":"10.1126\/scisignal.2003579","article-title":"Inflammatory factors contribute to depression and its comorbid conditions","volume":"5","author":"Anisman","year":"2012","journal-title":"Sci. Signal."},{"issue":"9","key":"10.1016\/j.jad.2019.03.008_bib0002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"issue":"1615","key":"10.1016\/j.jad.2019.03.008_bib0003","article-title":"Serotonin and beyond: therapeutics for major depression","volume":"368","author":"Blier","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.jad.2019.03.008_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2015.05.027","article-title":"Neurotrophic factors in depression in response to treatment","volume":"183","author":"Buttenschon","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.03.008_bib0005","first-page":"209","article-title":"Escitalopram: a new SSRI for the treatment of depression in primary care","volume":"4","author":"Culpepper","year":"2002","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2019.03.008_bib0006","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2019.03.008_bib0007","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2019.03.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001547","article-title":"Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.jad.2019.03.008_bib0009","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737175.2017.1283217","article-title":"Investigational drugs in recent clinical trials for treatment-resistant depression","volume":"17","author":"Garay","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2019.03.008_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2014.07.035","article-title":"Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder","volume":"579","author":"He","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.jad.2019.03.008_bib0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2019.03.008_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0000000000000377","article-title":"The potential of predictive analytics to provide clinical decision support in depression treatment planning","volume":"31","author":"Kessler","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2019.03.008_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"Kohler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.jad.2019.03.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192455","article-title":"Production of fluorescent antibody-labeling proteins in plants using a viral vector and the application in the detection of Acidovorax citrulli and Bamboo mosaic virus","volume":"13","author":"Kuo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2019.03.008_bib0015","first-page":"1393","article-title":"Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment","volume":"10","author":"Lee","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.03.008_bib0016","doi-asserted-by":"crossref","first-page":"435","DOI":"10.31887\/DCNS.2009.11.4\/afleuchter","article-title":"A new paradigm for the prediction of antidepressant treatment response","volume":"11","author":"Leuchter","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jad.2019.03.008_bib0017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2190\/PM.46.2.g","article-title":"Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls","volume":"46","author":"Matsuzaka","year":"2013","journal-title":"Int. J. Psychiatry Med."},{"issue":"3\u20134","key":"10.1016\/j.jad.2019.03.008_bib0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","article-title":"Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy","volume":"41","author":"O'Brien","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2019.03.008_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopsych.2012.12.007","article-title":"A clinical risk stratification tool for predicting treatment resistance in major depressive disorder","volume":"74","author":"Perlis","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2019.03.008_bib0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2016.02.026","article-title":"Fibroblast growth factor 2 modulates hypothalamic pituitary axis activity and anxiety behavior through glucocorticoid receptors","volume":"80","author":"Salmaso","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2019.03.008_bib0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijms19082410","article-title":"The efficacy of buprenorphine in major depression, treatment-resistant depression and suicidal behavior: a systematic review","volume":"19","author":"Serafini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jad.2019.03.008_bib0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bdi.12026","article-title":"Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review","volume":"15","author":"Sienaert","year":"2013","journal-title":"Bipolar Disord."},{"issue":"12","key":"10.1016\/j.jad.2019.03.008_bib0023","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.2010.09111680","article-title":"Personalized medicine for depression: can we match patients with treatments?","volume":"167","author":"Simon","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2019.03.008_bib0024","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/JCP.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients","volume":"70","author":"Szegedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"585","key":"10.1016\/j.jad.2019.03.008_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3399\/bjgp11X567036","article-title":"Involving patients with depression in research: survey of patients' attitudes to participation","volume":"61","author":"Tallon","year":"2011","journal-title":"Br. J. Gen. Pract."},{"issue":"4","key":"10.1016\/j.jad.2019.03.008_bib0026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","article-title":"Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder","volume":"170","author":"Tuglu","year":"2003","journal-title":"Psychopharmacology"},{"issue":"05","key":"10.1016\/j.jad.2019.03.008_bib0027","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1017\/S0033291711001905","article-title":"Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms","volume":"42","author":"Uher","year":"2012","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.jad.2019.03.008_bib0028","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718330982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718330982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:22:57Z","timestamp":1759022577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718330982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"alternative-id":["S0165032718330982"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.008","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}